↓ Skip to main content

Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors

Overview of attention for article published in Clinical Sarcoma Research, June 2014
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#46 of 104)
  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors
Published in
Clinical Sarcoma Research, June 2014
DOI 10.1186/2045-3329-4-5
Pubmed ID
Authors

Eirini Thanopoulou, Khin Thway, Komel Khabra, Ian Judson

Abstract

Aromatase inhibitors (AIs) have not been used consistently as part of the management of hormone receptor positive uterine leiomyosarcomas (ULMS). As a result, the published data regarding the efficacy of AIs in this subtype of ULMS are sparse.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Other 7 23%
Student > Ph. D. Student 4 13%
Student > Postgraduate 4 13%
Researcher 4 13%
Student > Bachelor 2 7%
Other 0 0%
Unknown 9 30%
Readers by discipline Count As %
Medicine and Dentistry 11 37%
Agricultural and Biological Sciences 4 13%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Nursing and Health Professions 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 2 7%
Unknown 9 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2014.
All research outputs
#13,917,225
of 22,758,963 outputs
Outputs from Clinical Sarcoma Research
#46
of 104 outputs
Outputs of similar age
#116,737
of 227,901 outputs
Outputs of similar age from Clinical Sarcoma Research
#2
of 5 outputs
Altmetric has tracked 22,758,963 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 104 research outputs from this source. They receive a mean Attention Score of 3.4. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,901 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.